- cafead Apr 20, 2022 at 11:32: AM
via Johnson & Johnson remains focused on both internal innovation as well as merger and acquisition opportunities. That includes the company's medtech business.
During the company's first-quarter 2022 earnings call on Tuesday, Joe Wolk, executive VP and CFO at Johnson & Johnson, said the company increased R&D investment in the first quarter by about 9% compared to the same period last year.
article source
During the company's first-quarter 2022 earnings call on Tuesday, Joe Wolk, executive VP and CFO at Johnson & Johnson, said the company increased R&D investment in the first quarter by about 9% compared to the same period last year.
article source